Share
𝕏 Facebook LinkedIn

Acceleration of the development of benzopyrene-induced skin cancer in mice by microwave radiation.

PAPER pubmed Archives of dermatological research 1982 Animal study Effect: harm Evidence: Low

Abstract

Development and growth of skin cancer may be affected by various physical and chemical factors present in human environment. Of these factors electromagnetic radiation of radio- and microwave spectra are among the most common. In the present study Balb/c mice were exposed to chemical carcinogen, 3,4-benzopyrene, painted on the skin every 2nd day for a total of 6 months, and simultaneously irradiated with athermal (5 mW/cm2) or subthermal (15 mW/cm2) doses of 2,450 MHz microwaves. The other group of animals was preirradiated with microwaves at 10 mW/cm2 power level for 1, 2, or 3 months and then treated with benzopyrene, as above. Control mice were exposed for 6 months to benzopyrene, resulting in the development of baso- or spinocellular skin carcinoma within approximately 9 months, and sham-irradiated with microwaves. The growth of the tumour was assessed according to a self-designed 7-range macroscopic scale, supported by microscopical examinations of skin sections. All protocols of microwave irradiations resulted in a significant acceleration of the development of benzopyrene-induced skin cancer and in shortening of life span of the tumour-bearing hosts. This effect seemed to be dose-dependent since subthermal doses (15 mV/cm2) and longer (3 months) expositions to microwaves were more efficient as compared to athermal doses (5 mW/cm2) and shorter preirradiations. In addition, low-level, long-lasting exposure to microwaves led to a marked suppression of delayed hypersensitivity of mice treated with benzopyrene, as assessed by their reactivity to dinitrofluorbenzene (DNFB). It is suggested that the observed co-carcinogenic effect of microwave radiation may, at least in part, result from the inhibitory action of microwaves on cellular immune reactions of exposed animals.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
harm
Population
Balb/c mice
Sample size
Exposure
microwave · 2450 MHz · Simultaneous exposure during 6 months of benzopyrene treatment; or preirradiation for 1, 2, or 3 months before benzopyrene treatment
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

All microwave irradiation protocols (2,450 MHz at 5, 10, or 15 mW/cm2; described as athermal or subthermal) significantly accelerated development of benzopyrene-induced skin cancer and shortened lifespan of tumor-bearing mice versus sham-irradiated controls. Effects appeared dose-dependent, with 15 mW/cm2 and longer (3-month) preirradiation more effective than 5 mW/cm2 and shorter preirradiations. Long-lasting low-level microwave exposure was associated with suppressed delayed hypersensitivity (DNFB reactivity) in benzopyrene-treated mice.

Outcomes measured

  • Development/latency of benzopyrene-induced skin cancer (baso- or spinocellular carcinoma)
  • Tumor growth (macroscopic scale; supported by microscopy)
  • Life span of tumor-bearing mice
  • Delayed hypersensitivity (DNFB reactivity)

Limitations

  • Sample size not reported in abstract
  • Exposure metric reported as power density (mW/cm2) without SAR or dosimetry details
  • Tumor growth assessed using a self-designed macroscopic scale (validation not described)
  • Mechanistic interpretation (immune suppression) is suggested rather than directly established

Suggested hubs

  • who-icnirp (0.25)
    Animal study on microwave exposure and cancer outcomes relevant to RF health-risk evaluations.
View raw extracted JSON
{
    "study_type": "animal",
    "exposure": {
        "band": "microwave",
        "source": null,
        "frequency_mhz": 2450,
        "sar_wkg": null,
        "duration": "Simultaneous exposure during 6 months of benzopyrene treatment; or preirradiation for 1, 2, or 3 months before benzopyrene treatment"
    },
    "population": "Balb/c mice",
    "sample_size": null,
    "outcomes": [
        "Development/latency of benzopyrene-induced skin cancer (baso- or spinocellular carcinoma)",
        "Tumor growth (macroscopic scale; supported by microscopy)",
        "Life span of tumor-bearing mice",
        "Delayed hypersensitivity (DNFB reactivity)"
    ],
    "main_findings": "All microwave irradiation protocols (2,450 MHz at 5, 10, or 15 mW/cm2; described as athermal or subthermal) significantly accelerated development of benzopyrene-induced skin cancer and shortened lifespan of tumor-bearing mice versus sham-irradiated controls. Effects appeared dose-dependent, with 15 mW/cm2 and longer (3-month) preirradiation more effective than 5 mW/cm2 and shorter preirradiations. Long-lasting low-level microwave exposure was associated with suppressed delayed hypersensitivity (DNFB reactivity) in benzopyrene-treated mice.",
    "effect_direction": "harm",
    "limitations": [
        "Sample size not reported in abstract",
        "Exposure metric reported as power density (mW/cm2) without SAR or dosimetry details",
        "Tumor growth assessed using a self-designed macroscopic scale (validation not described)",
        "Mechanistic interpretation (immune suppression) is suggested rather than directly established"
    ],
    "evidence_strength": "low",
    "confidence": 0.7399999999999999911182158029987476766109466552734375,
    "peer_reviewed_likely": "yes",
    "keywords": [
        "microwave radiation",
        "2450 MHz",
        "power density",
        "athermal",
        "subthermal",
        "benzopyrene",
        "skin cancer",
        "Balb/c mice",
        "co-carcinogenic effect",
        "delayed hypersensitivity",
        "DNFB",
        "immune suppression"
    ],
    "suggested_hubs": [
        {
            "slug": "who-icnirp",
            "weight": 0.25,
            "reason": "Animal study on microwave exposure and cancer outcomes relevant to RF health-risk evaluations."
        }
    ]
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.